APA (7th ed.) Citation

Guo, J., Li, M., Zhang, L., Zhang, Q., Wang, N., Wei, Y., . . . Gao, C. (2026). Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma. Leukemia & Lymphoma, 67(3), 685. https://doi.org/10.1080/10428194.2025.2605516

Chicago Style (17th ed.) Citation

Guo, Jiayuan, et al. "Clinical Outcomes of Modified Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for T-cell Acute Lymphoblastic Leukemia/lymphoma." Leukemia & Lymphoma 67, no. 3 (2026): 685. https://doi.org/10.1080/10428194.2025.2605516.

MLA (9th ed.) Citation

Guo, Jiayuan, et al. "Clinical Outcomes of Modified Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for T-cell Acute Lymphoblastic Leukemia/lymphoma." Leukemia & Lymphoma, vol. 67, no. 3, 2026, p. 685, https://doi.org/10.1080/10428194.2025.2605516.